Synthesis of Silver‐Based Plasmas by Plant Extracts for In Vitro PTT/PDT/CT Synergistic Antitumor Therapy. (15th November 2022)
- Record Type:
- Journal Article
- Title:
- Synthesis of Silver‐Based Plasmas by Plant Extracts for In Vitro PTT/PDT/CT Synergistic Antitumor Therapy. (15th November 2022)
- Main Title:
- Synthesis of Silver‐Based Plasmas by Plant Extracts for In Vitro PTT/PDT/CT Synergistic Antitumor Therapy
- Authors:
- Xie, Yiliang
Dong, Baowen
Zhang, Xuan
Fan, Jimin
Lin, Jianying
Zhang, Bing
Zhao, Zhihuan - Abstract:
- Abstract: In this study, biosynthetic Ag@AgCl plasma is used as a photosensitizer for the first time to construct a photothermal/photodynamic/chemotherapy and pH‐responsive synergistic antitumor nanomedicine delivery system CS‐Ag@AgCl/C. The Ag@AgCl and AgNPs synthesized by the extracts of alpine banana, C itrus reticulata, and Citrus sinensis are characterized. The Ag@AgCl NPs synthesized with banana extract have a regular crystal shape and a granular size of 12 nm, and they are more stable than AgNPs synthesized with the other two extracts. In addition, Ag@AgCl plasma used as a photosensitizer can reduce the dependence of CS‐Ag@AgCl/C on oxygen in the photodynamic process. After coating with chitosan, though the photothermal conversion efficiency of CS‐Ag@AgCl/C decreases from 44.06% to 29.51%, the pH response character of it increases, and the pH response plays an important role in drug release experiments. Under an acidic environment of pH = 5.0 phosphate‐buffered saline buffer, the drug release rate of the samples increases significantly. In the synergistic antitumor experiment, the cell survival rate increases from 36.83% to 78.69% after chitosan‐coated Ag@AgCl/C NPs. When CS‐Ag@AgCl/C‐DOX+808 nm is co‐cultured with HeLa cells, the cell survival rate is only 14.89%, which indicates that the constructed plasma drug delivery system has excellent photothermal/photodynamic/chemotherapy combined treatment capability. Abstract : A pH‐responsive drug delivery systemAbstract: In this study, biosynthetic Ag@AgCl plasma is used as a photosensitizer for the first time to construct a photothermal/photodynamic/chemotherapy and pH‐responsive synergistic antitumor nanomedicine delivery system CS‐Ag@AgCl/C. The Ag@AgCl and AgNPs synthesized by the extracts of alpine banana, C itrus reticulata, and Citrus sinensis are characterized. The Ag@AgCl NPs synthesized with banana extract have a regular crystal shape and a granular size of 12 nm, and they are more stable than AgNPs synthesized with the other two extracts. In addition, Ag@AgCl plasma used as a photosensitizer can reduce the dependence of CS‐Ag@AgCl/C on oxygen in the photodynamic process. After coating with chitosan, though the photothermal conversion efficiency of CS‐Ag@AgCl/C decreases from 44.06% to 29.51%, the pH response character of it increases, and the pH response plays an important role in drug release experiments. Under an acidic environment of pH = 5.0 phosphate‐buffered saline buffer, the drug release rate of the samples increases significantly. In the synergistic antitumor experiment, the cell survival rate increases from 36.83% to 78.69% after chitosan‐coated Ag@AgCl/C NPs. When CS‐Ag@AgCl/C‐DOX+808 nm is co‐cultured with HeLa cells, the cell survival rate is only 14.89%, which indicates that the constructed plasma drug delivery system has excellent photothermal/photodynamic/chemotherapy combined treatment capability. Abstract : A pH‐responsive drug delivery system (CS‐Ag@AgCl/C) is constructed using biosynthesized Ag@AgCl plasma as a photosensitizer, hollow carbon nanoparticles as a carrier, and chitosan as a shell. Doxorubicin shedding from chitosan is induced by a slightly acidic tumor site; under the irradiation of 808 nm laser, the temperature of nanoparticles increases while producing reactive oxygen species, realizing the combination of photothermal, photodynamic, and chemotherapy. … (more)
- Is Part Of:
- Particle and particle systems characterization. Volume 40:Number 1(2023)
- Journal:
- Particle and particle systems characterization
- Issue:
- Volume 40:Number 1(2023)
- Issue Display:
- Volume 40, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 40
- Issue:
- 1
- Issue Sort Value:
- 2023-0040-0001-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-11-15
- Subjects:
- combination therapies -- CS‐Ag@AgCl/C plasma -- green synthesis -- pH‐responsive
Particles -- Periodicals
620.43 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-4117 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ppsc.202200159 ↗
- Languages:
- English
- ISSNs:
- 0934-0866
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6407.310000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25145.xml